| P2093 | author name string | Romain R Vivès | |
| | Evelyne Gout | |
| | Rana El Masri | |
| | Yoann Crétinon | |
| P2860 | cites work | Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4 | Q75197360 |
| | Elastase-mediated release of heparan sulfate proteoglycans from pulmonary fibroblast cultures. A mechanism for basic fibroblast growth factor (bFGF) release and attenuation of bfgf binding following elastase-induced injury | Q78151582 |
| | Heparan sulfate expression is affected by inflammatory stimuli in primary human endothelial cells | Q83082230 |
| | Mammalian Sulf1 RNA alternative splicing and its significance to tumour growth regulation | Q84381536 |
| | Macrophage polarization alters the expression and sulfation pattern of glycosaminoglycans | Q86280024 |
| | Heparan sulfate S-domains and extracellular sulfatases (Sulfs): their possible roles in protein aggregation diseases | Q90020281 |
| | Expression and purification of recombinant extracellular sulfatase HSulf-2 allows deciphering of enzyme sub-domain coordinated role for the binding and 6-O-desulfation of heparan sulfate | Q91784179 |
| | Heparan sulfate in chronic kidney diseases: Exploring the role of 3-O-sulfation | Q91833819 |
| | Loss of endothelial sulfatase-1 after experimental sepsis attenuates subsequent pulmonary inflammatory responses | Q92955695 |
| | Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival | Q21144445 |
| | Proteoglycan form and function: A comprehensive nomenclature of proteoglycans | Q21710680 |
| | Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans | Q24309373 |
| | Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domain | Q24322725 |
| | Functional consequences of the subdomain organization of the sulfs | Q24337783 |
| | HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. | Q24541580 |
| | Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins | Q24552437 |
| | Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2 | Q24673634 |
| | Subendothelial heparan sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein-1 ligands upon renal ischemia/reperfusion | Q24683770 |
| | Heparan Sulfate Proteoglycan Metabolism and the Fate of Grafted Tissues | Q26797410 |
| | The chemokine superfamily revisited | Q26824492 |
| | Functional aspects of the interaction between interleukin-8 and sulfated glycosaminoglycans | Q26865592 |
| | Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation | Q27009264 |
| | Heparan Sulfate Proteoglycans Mediate Attachment and Entry of Human T-Cell Leukemia Virus Type 1 Virions into CD4+ T Cells | Q27472216 |
| | Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes | Q30497539 |
| | Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra | Q30568524 |
| | Heparan sulfate and chondroitin sulfate proteoglycans inhibit E-selectin binding to endothelial cells | Q31910675 |
| | Substrate specificity and domain functions of extracellular heparan sulfate 6-O-endosulfatases, QSulf1 and QSulf2. | Q33230305 |
| | Substrate specificity of 6-O-endosulfatase (Sulf-2) and its implications in synthesizing anticoagulant heparan sulfate | Q33401779 |
| | Modulation of Interleukin-12 activity in the presence of heparin | Q33903041 |
| | Structural diversity of heparan sulfate binding domains in chemokines | Q34008721 |
| | Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase | Q34089065 |
| | TLR4 dependent heparan sulphate-induced pancreatic inflammatory response is IRF3-mediated | Q34107852 |
| | Heparanase: a key enzyme involved in cell invasion | Q34183747 |
| | Syndecan-1 in B lymphoid malignancies | Q34571297 |
| | HSulf sulfatases catalyze processive and oriented 6-O-desulfation of heparan sulfate that differentially regulates fibroblast growth factor activity | Q34606182 |
| | Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines | Q34762409 |
| | Leukocyte extravasation: chemokine transport and presentation by the endothelium | Q34998445 |
| | Heparan sulfate proteoglycans | Q35059448 |
| | Syndecans in inflammation | Q35094731 |
| | Interleukin-2 is present in human blood vessels and released in biologically active form by heparanase | Q35181984 |
| | Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4. | Q35312128 |
| | Ligands for L-selectin: homing, inflammation, and beyond | Q35698423 |
| | Heparin-induced leukocytosis requires 6-O-sulfation and is caused by blockade of selectin- and CXCL12 protein-mediated leukocyte trafficking in mice | Q35774009 |
| | Synthetic heparan sulfate dodecasaccharides reveal single sulfation site interconverts CXCL8 and CXCL12 chemokine biology. | Q36169514 |
| | Inactivation of heparan sulfate 2-O-sulfotransferase accentuates neutrophil infiltration during acute inflammation in mice. | Q36194268 |
| | Monocyte adhesion to activated aortic endothelium: role of L-selectin and heparan sulfate proteoglycans | Q36254610 |
| | The biological relevance of chemokine-proteoglycan interactions | Q36482111 |
| | The role of heparan sulphate in inflammation | Q36569379 |
| | Overexpression of Sulf2 in idiopathic pulmonary fibrosis | Q36811065 |
| | The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. | Q37045970 |
| | Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines | Q37373049 |
| | Interactions between heparan sulfate and proteins-design and functional implications | Q37543699 |
| | Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate | Q37772524 |
| | Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function | Q37827607 |
| | Post-Synthetic Regulation of HS Structure: The Yin and Yang of the Sulfs in Cancer | Q38181492 |
| | Matrix metalloproteinases in inflammation. | Q38196164 |
| | The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate. | Q38290246 |
| | Alterations in heparan sulfate in the vessel in response to vascular injury in the mouse | Q38294955 |
| | Characterization of the stromal cell-derived factor-1alpha-heparin complex | Q38306497 |
| | Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation | Q38314015 |
| | Defining the interleukin-8-binding domain of heparan sulfate | Q38336349 |
| | Endothelial inflammation: the role of differential expression of N-deacetylase/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate | Q38352336 |
| | A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization | Q38359935 |
| | The sweet spot: how GAGs help chemokines guide migrating cells | Q38678399 |
| | Regulation of the Expression of Heparan Sulfate 3-O-Sulfotransferase 3B (HS3ST3B) by Inflammatory Stimuli in Human Monocytes | Q38819007 |
| | Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis | Q39001710 |
| | Tunable heparan sulfate mimetics for modulating chemokine activity | Q39121360 |
| | Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents | Q39799215 |
| | A novel SULF1 splice variant inhibits Wnt signalling but enhances angiogenesis by opposing SULF1 activity | Q39829323 |
| | Glycanogenomics: a qPCR-approach to investigate biological glycan function | Q39951997 |
| | Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo | Q39978694 |
| | Heparan sulfate domains on cultured activated glomerular endothelial cells mediate leukocyte trafficking. | Q40072351 |
| | Heparan sulfate on activated glomerular endothelial cells and exogenous heparinoids influence the rolling and adhesion of leucocytes. | Q40178840 |
| | Transcriptional Induction of Periostin by a Sulfatase 2-TGFβ1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma. | Q40463354 |
| | Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. | Q40528868 |
| | Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action | Q40935758 |
| | Heparan sulfate/heparin N-deacetylase/N-sulfotransferase. The N-sulfotransferase activity domain is at the carboxyl half of the holoenzyme | Q41007046 |
| | Ligation of cell surface heparan sulfate proteoglycans by antibody-coated beads stimulates phagocytic uptake into epithelial cells: a model for cellular invasion by Neisseria gonorrhoeae. | Q41021116 |
| | Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence | Q41186157 |
| | The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors. | Q42152393 |
| | Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis | Q42291940 |
| | Role of 6-O-sulfated heparan sulfate in chronic renal fibrosis. | Q42742727 |
| | High-affinity binding sites for heparin generated on leukocytes during apoptosis arise from nuclear structures segregated during cell death | Q43904544 |
| | Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses | Q46806608 |
| | Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression | Q47377873 |
| | Heparan Sulfate Proteoglycans as Relays of Neuroinflammation. | Q47888806 |
| | Specificity of glycosaminoglycan-protein interactions | Q49894342 |
| | Epithelial Deletion of Sulf2 Exacerbates Bleomycin-Induced Lung Injury, Inflammation, and Mortality. | Q50918830 |
| | Tumour-necrosis factor-α induces heparan sulfate 6-O-endosulfatase 1 (Sulf-1) expression in fibroblasts. | Q51442367 |
| | Heparan Sulfate: Biosynthesis, Structure, and Function. | Q51729668 |
| | Sulf2 gene is alternatively spliced in mammalian developing and tumour tissues with functional implications. | Q51851865 |
| | Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells. | Q52544831 |
| | Phenotypic and Functional Maturation of Dendritic Cells Mediated by Heparan Sulfate | Q56967640 |
| | Transcytosis and Surface Presentation of IL-8 by Venular Endothelial Cells | Q57419171 |
| | SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression | Q57829104 |
| | Heparan sulfate as a regulator of inflammation and immunity | Q58096427 |
| | The glycocalyx: a novel diagnostic and therapeutic target in sepsis | Q61446862 |
| | L-selectin: A Major Regulator of Leukocyte Adhesion, Migration and Signaling | Q64268554 |
| | Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules | Q71557017 |
| | Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: evidence for cytokine dependence and detection of a novel sulfatase | Q72349595 |
| | Heparan sulfate initiates signals in murine macrophages leading to divergent biologic outcomes | Q72393061 |
| | Regulation of T cell homeostasis by heparan sulfate-bound IL-2 | Q73002918 |
| | Involvement of heparan sulfate proteoglycans in the binding step for phagocytosis of latex beads by Chinese hamster ovary cells | Q73025501 |
| | Specific binding of the chemokine platelet factor 4 to heparan sulfate | Q73575394 |
| | Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes | Q73765278 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 570 | |
| P577 | publication date | 2020-04-03 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | HS and Inflammation: A Potential Playground for the Sulfs? | |
| P478 | volume | 11 | |